• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用智能纳米载体实现癌症治疗的 siRNA 传递的最新进展。

Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.

机构信息

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China; Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, China.

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China; Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, China.

出版信息

Drug Discov Today. 2018 Apr;23(4):900-911. doi: 10.1016/j.drudis.2018.01.042. Epub 2018 Jan 31.

DOI:10.1016/j.drudis.2018.01.042
PMID:29373841
Abstract

Small interfering RNAs (siRNAs) can selectively target and downregulate disease-causing genes, holding great promise in treating human diseases, especially malignant cancers. However, how to efficiently deliver siRNAs into target cell cytosol is a problem that has hindered their clinical application. Here, we review the recent strategies for siRNA delivery on the basis of smart nanocarriers by using stimuli-responsive materials. We highlight the rationales of how to design smart nanocarriers responsive to physiological and external stimuli to improve the delivery efficiency, targeting precision and gene silencing efficacy. Finally, we provide an outlook on the fundamental limitation for clinical translation of siRNA-based nanomedicine that should be overcome by the combination of chemistry, biology, material and medical science.

摘要

小干扰 RNA(siRNAs)可以选择性地靶向和下调致病基因,在治疗人类疾病,特别是恶性癌症方面具有巨大的应用前景。然而,如何将 siRNAs 高效递送至靶细胞胞质溶胶是一个阻碍其临床应用的问题。在这里,我们基于智能纳米载体,综述了使用刺激响应性材料进行 siRNA 递送的最新策略。我们重点介绍了如何设计对生理和外部刺激有响应的智能纳米载体,以提高递送效率、靶向精度和基因沉默效果。最后,我们对基于 siRNA 的纳米医学向临床转化的基本限制进行了展望,认为这需要化学、生物学、材料学和医学的结合来克服。

相似文献

1
Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.利用智能纳米载体实现癌症治疗的 siRNA 传递的最新进展。
Drug Discov Today. 2018 Apr;23(4):900-911. doi: 10.1016/j.drudis.2018.01.042. Epub 2018 Jan 31.
2
Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.肿瘤靶向多功能纳米颗粒用于 siRNA 递送:癌症治疗的新进展。
Adv Healthc Mater. 2014 Aug;3(8):1182-93. doi: 10.1002/adhm.201300607. Epub 2014 Feb 28.
3
Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.肿瘤酸度裂解马来酸酰胺(TACMAA):设计智能纳米粒子克服癌症纳米医学中输送障碍的强大工具。
Acc Chem Res. 2018 Nov 20;51(11):2848-2856. doi: 10.1021/acs.accounts.8b00195. Epub 2018 Oct 15.
4
Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.用于癌症治疗中 siRNA 递送的基于脂质的纳米颗粒:范例与挑战。
Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8.
5
Chitosan Nanoparticles for SiRNA Delivery In Vitro.用于体外递送小干扰RNA的壳聚糖纳米颗粒
Methods Mol Biol. 2016;1364:143-50. doi: 10.1007/978-1-4939-3112-5_12.
6
Strategies and advances in nanomedicine for targeted siRNA delivery.纳米医学靶向 siRNA 递送的策略和进展。
Nanomedicine (Lond). 2011 Jun;6(4):729-46. doi: 10.2217/nnm.11.15.
7
The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.RNAi 疗法的潜力与进展:siRNA 分子的化学和结构修饰及生物相容纳米载体的应用。
J Control Release. 2014 Nov 10;193:113-21. doi: 10.1016/j.jconrel.2014.05.030. Epub 2014 May 24.
8
Delivering siRNA with Dendrimers: In Vivo Applications.利用树枝状大分子递送小干扰RNA:体内应用
Curr Gene Ther. 2017;17(2):105-119. doi: 10.2174/1566523217666170510160527.
9
The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy.纳米粒子-siRNA 与抗癌剂共递运在癌症治疗中的重要性。
Chem Biol Drug Des. 2021 Apr;97(4):997-1015. doi: 10.1111/cbdd.13824. Epub 2021 Feb 18.
10
Advances in stimuli responsive nanobiomaterials for cancer therapy.刺激响应型纳米生物材料在癌症治疗中的研究进展。
J Biomed Nanotechnol. 2014 Mar;10(3):367-82. doi: 10.1166/jbn.2014.1778.

引用本文的文献

1
Targeting tumor immune evasion: the role of PD-L1 siRNA in advancing cancer immunotherapy.靶向肿瘤免疫逃逸:PD-L1小干扰RNA在推进癌症免疫治疗中的作用
Med Oncol. 2025 Sep 13;42(11):471. doi: 10.1007/s12032-025-03025-4.
2
Current views and trends of nanomaterials as vectors for gene delivery since the 21st century: a bibliometric analysis.21世纪以来纳米材料作为基因传递载体的当前观点与趋势:一项文献计量分析
Nanomedicine (Lond). 2025 Mar;20(5):439-454. doi: 10.1080/17435889.2025.2457781. Epub 2025 Jan 29.
3
siRNA-based strategies to combat drug resistance in gastric cancer.
基于 siRNA 的策略来对抗胃癌的耐药性。
Med Oncol. 2024 Oct 21;41(11):293. doi: 10.1007/s12032-024-02528-w.
4
Hybrid Liposome-MSN System with Co-Delivering Potential Effective Against Multidrug-Resistant Tumor Targets in Mice Model.载药介孔硅纳米粒的杂化脂质体系统对荷瘤小鼠多药耐药肿瘤的协同靶向治疗作用
Int J Nanomedicine. 2024 Sep 2;19:8949-8970. doi: 10.2147/IJN.S472276. eCollection 2024.
5
Emerging delivery approaches for targeted pulmonary fibrosis treatment.靶向肺纤维化治疗的新兴给药途径。
Adv Drug Deliv Rev. 2024 Jan;204:115147. doi: 10.1016/j.addr.2023.115147. Epub 2023 Dec 6.
6
Advances in modification and delivery of nucleic acid drugs.核酸药物的修饰和递送技术的进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Aug 25;52(4):417-428. doi: 10.3724/zdxbyxb-2023-0130.
7
Elimination of Cancer Cells in Co-Culture: Role of Different Nanocarriers in Regulation of CD47 and Calreticulin-Induced Phagocytosis.共培养体系中癌细胞的清除:不同纳米载体在调控 CD47 和钙网织蛋白诱导的吞噬作用中的作用。
ACS Appl Mater Interfaces. 2023 Jan 25;15(3):3791-3803. doi: 10.1021/acsami.2c19311. Epub 2023 Jan 12.
8
pH-Sensitive Polyacrylic Acid-Gated Mesoporous Silica Nanocarrier Incorporated with Calcium Ions for Controlled Drug Release.结合钙离子的pH敏感型聚丙烯酸门控介孔二氧化硅纳米载体用于药物控释
Materials (Basel). 2022 Aug 27;15(17):5926. doi: 10.3390/ma15175926.
9
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma.用于增强黑色素瘤治疗的超声响应性靶向Nrf2的负载小干扰RNA纳米气泡
Pharmaceutics. 2022 Jan 31;14(2):341. doi: 10.3390/pharmaceutics14020341.
10
Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy.阳离子肽修饰的金纳米星作为RNA干扰抗肿瘤治疗的高效递送平台
Polymers (Basel). 2021 Oct 30;13(21):3764. doi: 10.3390/polym13213764.